Skip to main content
Clinical Trials/NCT05723861
NCT05723861CompletedNot Applicable

Virtual Reality During Colonoscopy

Herlev and Gentofte Hospital1 site in 1 country50 target enrollmentStarted: March 22, 2023Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
50
Locations
1
Primary Endpoint
Patient pain before colonoscopy procedure

Study Overview

Brief Summary

This project will use a randomized controlled trial to test the effect of using Virtual Reality on pain, anxiety, patients' comfort, and satisfaction during colonoscopy. Patients will use a virtual reality head-mounted display and choose a visualized VR content to watch during colonoscopy. Colonoscopy will be initiated without standard sedatives and narcotics and using virtual reality distraction for as long as the patient would like (for a maximum of 20 minutes). Participants could opt out and/or request standard medications for pain at any time before or during the procedure.

Detailed Description

This project aims to investigate the clinical effectiveness and implementation potential of using VR during colonoscopy using a hybrid type 1 effectiveness-implementation design through 2 work packages. The first work package will investigate the effect of VR on pain, anxiety, patients' comfort, and satisfaction during colonoscopy using a multicenter parallel randomized controlled, open-label trial. It will also be a qualitative interview to explore the healthcare professionals' and patients' experiences with using VR during colonoscopy.

The second work package will evaluate the implementation process using mix method to understand why the intervention is (or is not) more effective than usual care, whether high intervention fidelity is achieved, what barriers and facilitators there are, how these may translate into real-world implementation, and what modifications can be made to maximize implementation success. This will be achieved using quantitative and qualitative approaches with a focus on the process evaluation around the RE-AIM framework (Reach, Effectiveness, Adoption, Implementation, and Maintenance). Quantitative (e.g., quantitative analysis of patient participation rate and reasons for refusal assessment or ineligibility) and qualitative (e.g., qualitative interview of facilitators/barriers to implementing VR) data analyses will be combined to conclude the reach, adoption, implementation, and maintenance of the intervention.

The specific aims of the project will be pursued through 2 work packages and include:

Intervention effectiveness work package Study I: To investigate the effect of VR on pain, anxiety, patients' comfort, and satisfaction during colonoscopy.

Study II: To explore the healthcare professionals' and patients' experiences with using VR during colonoscopy.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •any elective indication of colonoscopy

Exclusion Criteria

  • •having visual impairments,
  • •having dementia
  • •limited Danish language skills
  • •a high tendency to travel sickness
  • •having skin disease in the facial area
  • •having epilepsy

Arms & Interventions

VR group

Experimental

Participants will receive Virtual Reality intervention in addition to routine care during colonoscopy.

Intervention: VR (Device)

Control group

No Intervention

Receive routine treatment.

Outcomes

Primary Outcomes

Patient pain before colonoscopy procedure

Time Frame: 5 - 15 minutes before starting colonoscopy.

Patients will rate their pain using an 11-point numeric rating scale (NRS) ranging from 0 (no pain) to 10 (highest imaginable pain).

Patient anxiety after colonoscopy procedure

Time Frame: 5 - 15 minutes after the colonoscopy is ended.

Patient anxiety will be measured by the short form of the State Trait Anxiety Inventory (STAI) which has five items with a 4-point Likert-type scale ranging from 0 to 3.

Patient comfort after colonoscopy procedure

Time Frame: 5 - 15 minutes after the colonoscopy is ended.

Patient comfort will be measured by a nurse/researcher using the five-point Modified. Gloucester Comfort Scale (MGCS) ranging from 1 (no discomfort) to 5 (severe discomfort).

Patient anxiety before colonoscopy procedure

Time Frame: 5 - 15 minutes before starting colonoscopy.

Patient anxiety will be measured by the short form of the State Trait Anxiety Inventory (STAI) which has five items with a 4-point Likert-type scale ranging from 0 to 3.

Patient pain during colonoscopy procedure

Time Frame: During the colonoscopy procedure (from the time colonoscopy is started until ended).

Patients will rate their pain using an 11-point numeric rating scale (NRS) ranging from 0 (no pain) to 10 (highest imaginable pain).

Patient pain after colonoscopy procedure

Time Frame: 5 - 15 minutes after the colonoscopy is ended.

Patients will rate their pain using an 11-point numeric rating scale (NRS) ranging from 0 (no pain) to 10 (highest imaginable pain).

Patient comfort during colonoscopy procedure

Time Frame: During the colonoscopy procedure (from the time colonoscopy is started until ended).

Patient comfort will be measured by a nurse/researcher using the five-point Modified. Gloucester Comfort Scale (MGCS) ranging from 1 (no discomfort) to 5 (severe discomfort).

Secondary Outcomes

  • Patient / healthcare professional experience with using VR during colonoscopy(30 minutes - one week after the procedure)
  • Patient satisfaction(5 - 15 minutes after the colonoscopy is ended.)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Mahdi Shamali

Postdoc Researcher

Herlev and Gentofte Hospital

Study Sites (1)

Loading locations...

Similar Trials